Trinity Biotech Profit Margin 2006-2018 | TRIB

Current and historical gross margin, operating margin and net profit margin for Trinity Biotech (TRIB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Trinity Biotech net profit margin as of September 30, 2018 is -22.76%.
Trinity Biotech Annual Profit Margins
Trinity Biotech Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.070B $0.097B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.412B 27.76
Medtronic (MDT) Ireland $123.010B 17.98
Stryker (SYK) United States $73.467B 26.97
Boston Scientific (BSX) United States $52.473B 25.58
Baxter (BAX) United States $39.558B 25.31
Zimmer Biomet Holdings (ZBH) United States $26.051B 16.68
Smith & Nephew SNATS (SNN) United Kingdom $17.542B 0.00
Canopy Growth (CGC) Canada $15.685B 0.00
ResMed (RMD) United States $14.159B 26.85
Aurora Cannabis (ACB) Canada $9.930B 70.07
Bio-Rad Laboratories (BIO) United States $9.309B 53.12
Hill-Rom Holdings (HRC) United States $6.934B 21.44
Perrigo (PRGO) Ireland $6.569B 10.65
Insulet (PODD) United States $5.896B 1989.40
GW Pharmaceuticals (GWPH) United Kingdom $5.140B 0.00
ICU Medical (ICUI) United States $4.857B 30.24
Haemonetics (HAE) United States $4.425B 39.25
Hutchison China MediTech (HCM) China $3.913B 0.00
Agios Pharmaceuticals (AGIO) United States $3.752B 0.00
Neogen (NEOG) United States $3.328B 51.11
NuVasive (NUVA) United States $2.858B 24.93
Quidel (QDEL) United States $2.654B 23.95
Aphria (APHA) $2.533B 112.44
National Vision Holdings (EYE) United States $2.263B 44.51
HEXO (HEXO) $1.414B 0.00
Cardiovascular Systems (CSII) United States $1.377B 988.50
VAREX IMAGING (VREX) United States $1.295B 25.34
Phibro Animal Health (PAHC) United States $1.292B 18.57
AtriCure (ATRC) United States $1.089B 0.00
MacroGenics (MGNX) United States $0.939B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Cerus (CERS) United States $0.874B 0.00
Omeros (OMER) United States $0.861B 0.00
PetIQ (PETQ) United States $0.843B 24.12
NanoString Technologies (NSTG) United States $0.751B 0.00
Meridian Bioscience (VIVO) United States $0.722B 21.52
OraSure Technologies (OSUR) United States $0.705B 30.89
Evolus (EOLS) United States $0.685B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.667B 22.70
TG Therapeutics (TGTX) United States $0.655B 0.00
LeMaitre Vascular (LMAT) United States $0.609B 28.99
Surmodics (SRDX) United States $0.603B 87.71
Quanterix (QTRX) United States $0.545B 0.00
BioLife Solutions (BLFS) United States $0.376B 154.92
Rockwell Medical (RMTI) United States $0.367B 0.00
Insys Therapeutics (INSY) United States $0.352B 0.00
Vapotherm (VAPO) United States $0.330B 0.00
Utah Medical Products (UTMD) United States $0.315B 20.48
Owens & Minor (OMI) United States $0.284B 3.94
Bovie Medical (APYX) United States $0.266B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.265B 0.00
Cytosorbents (CTSO) United States $0.260B 0.00
Zynex (ZYXI) United States $0.144B 15.37
Fonar (FONR) United States $0.142B 7.59
Surface Oncology (SURF) United States $0.126B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
Female Health (VERU) United States $0.095B 0.00
United-Guardian (UG) United States $0.088B 18.43
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.071B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.037B 0.00
Senestech (SNES) United States $0.027B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 16.00